NANS responds to California DWC order to discontinue coverage of non-opioid treatment options for...

The North American Neuromodulation Society (NANS) has issued a response to the California Division of Workers’ Compensation (DWC) order which adopts regulations to update the evidence-based...

Brave Dreams trial finds venous angioplasty “safe, but largely ineffective” for MS patients

Paolo Zamboni, Ferrara, Italy, the proponent of the chronic cerebrospinal venous insufficiency (CCSVI) theory, and his colleagues have reported that the randomised, double-blinded, sham...

Real-life use of EmboTrap shows comparable outcomes to large stroke studies

The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...

3D revascularisation device “valuable adjunct” to ADAPT

According to one presentation given at the Society of NeuroInterventional Surgery’s 14th Annual Meeting (SNIS; 24–27 July, Colorado Springs, USA) the 3D revascularisation device...

Laurent Pierot

Joshua A Hirsch

Giancarlo Barolat

(Visited 8,196 times, 1 visits today)